Role of Early API in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients
- Conditions
- Dysplastic Nodule
- Registration Number
- NCT07080372
- Lead Sponsor
- Superior University
- Brief Summary
Liver cirrhosis is a common consequence of chronic liver disease, resulting from sustained hepatic injury due to various etiologies. Cirrhosis predisposes individuals to the development of hepatocellular carcinoma (HCC), the most prevalent primary malignancy of the liver. Among cirrhotic patients, distinguishing between hepatocellular carcinoma and dysplastic nodules is crucial for timely diagnosis, treatment planning, and prognostic assessment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 73
- Patients with abnormal LFTs
- Liver lesions of various sizes
- Patients with chronic liver disease
- Individuals undergoing routine liver screening
- Willing participants who consent to the study
- Children less than 5years
- Patients who are allergic or have a history of allergy to contrast media
- Patients with deranged renal function tests
- Pregnant women
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method self administered proforma form 12 Months A clinical history form is a structured document used to gather comprehensive information about a patient's medical background and current health status. It typically includes sections for identifying patient demographics, past medical history, family history, social history, medications, allergies, and a detailed account of the current illness or complaint.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Lahore General Hospital
🇵🇰Lahore, Pakistan
Lahore General Hospital🇵🇰Lahore, Pakistan